CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled / 15 target
Drug / intervention
Experiential Phenomenological Interviewbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06133309
NCT06133309N/ACompletedOn Track (0.6/mo)Completion was 7mo ago

Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer·interventional·Posted Nov 15, 2023·Updated Jun 16, 2026

In Brief

A clinical study evaluating Experiential Phenomenological Interview for Depressive Disorder. Completed, enrolled 15 participants across 1 site.

Detailed Summary

Ketamine is an anaesthetic used in low doses to treat depressive disorders. A related molecule, Esketamine, has recently been launched on the market for the treatment of resistant depression. One of the side effects of ketamine, like Esketamine, is induction of transient dissociative state. Dissociation has been described as disruption in continuity of conscious thought and emotion, cognitive processes disorganisation and an alteration in self-perception and environment perception. A study of healthy volunteers receiving ketamine showed that this state was manifested by altered sensory perceptions, with increased noise sensitivity, visual distortions and altered time perception. Few studies have looked at this phenomenon in the Esketamine context. However, it is a frequent side effect. With ketamine, it has been shown that anxiety associated with dissociative experience reduces the antidepressant effect. Benzodiazepines use for anxiolytic purposes is also thought to limit the antidepressant effect. It is necessary to explore the Esketamine induced transient dissociative state in order to clarify this state and develop therapeutic strategies. The investigators have chosen a phenomenological approach, which is the only way to evaluate consciousness contents and structures, in order to explore this state using the experiential phenomenological interview.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedNov 15, 2023
Enrollment StartMar 19, 2024
Primary CompletionDec 1, 2025
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 2.6 years ago

Arms & Interventions

Depressive patientsexperimental

Patients suffering from depressive disorder and treated with Esketamine between 2 days and 3 months prior to the study.

Behavioral: Experiential Phenomenological Interview

Interventions

Experiential Phenomenological Interviewbehavioral

Consciousness fluidity of patients suffering from depressive disorder and treated with Esketamine will be evaluated thanks to Experiential Phenomenological Interview and EQFC "Trait" questionnaire